Here, we aimed to evaluate the prognostic role and clinical significance of the CRP-lymphocyte ratio (CLR), the combination of CRP and lymphocyte count, and classify CRC patients into different risk groups for personalized treatment and management. Here, CRP is linked to colorectal carcinoma.